Danish pharmaceutical company Novo Nordisk is to manufacture Wegovy in Co Roscommon following a site expansion.

On December 22, 2025, the U.S. Food and Drug Administration (FDA) approved an oral pill form of Wegovy — a glucagon-like peptide-1 (GLP-1) receptor agonist medication for weight loss. Until now, ...

The maker of the blockbuster weight loss and diabetes drugs Wegovy and Ozempic have cut the prices for most versions of these medications. Novo Nordisk dropped the price for injectable Wegovy and ...

This article was reviewed by Darragh O’Carroll, MD. Key takeaways: Wegovy® (semaglutide) is a once-a-week injection. It’s approved by the Food and Drug Administration (FDA) for weight loss in people ...

Wegovy and Zepbound, two popular weight loss GLP-1 medications, would remain cost-effective at a higher price, according to an Oct. 29 revised report from the Institute for Clinical and Economic ...

There’s no question that medications like semaglutide (Wegovy) and tirzepatide (Zepbound) make headlines. They’re two of the handful of medications approved specifically for weight loss. While both ...